Abstract:In this work, our primary objective was to examine the interrelationship among the serum level of chemokine (C-C motif) ligand 2 (CCL2) and plaque characteristics in coronary culprit lesions. The clinical data of 116 coronary heart disease patients who were hospitalized in the Department of Cardiology of Henan Province People's Hospital from February 2015 to June 2017 were retrospectively analyzed. The study population was subdivided according to the concentration of CCL2 into low CCL2 group and high CCL2 group. The levels of blood lipid, creatinine, and uric acid were measured, and patients underwent coronary angiography. The characteristics of the culprit lesions were detected by intravascular ultrasound, and the correlation between the serum markers and the characteristics of coronary artery plaque was analyzed. Moreover, the coronary artery disease dataset from the Gene Expression Omnibus database was downloaded and the genes regulated were analyzed by CCL2 using gene set enrichment analysis (GSEA). Patients with high CCL2 group had higher LDL-C level and L/H ratio, and lower HDL-C level than the low CCL2 group. Compared with low-level CCL2 group, coronary plaque in the high CCL2 group had higher eccentric plaque and plaque rupture, and thin cap fibroatheromas, fibrofatty and necrotic core and lower fibrous tissue. CCL2 was positively correlated with the percentage of fibrofatty and necrotic core, and negatively correlated with the percentage of fibrous tissue. Furthermore, GSEA analysis showed that samples with high CCL2 expression were enriched for genes involved in different pathways, such as cell adhesion molecules and Nod-like receptor signaling pathway. The CCL2 level was correlated with vulnerable plaques of coronary artery and had certain value in detecting vulnerable plaques. These results indicated that CCL2 could be regarded as a clinical prognostic biomarker for coronary artery disease. Impact statement Vulnerable plaques are plaques which are susceptible to rupture or thrombosis and trigger a series of adverse events such as coronary disorders. CCL2 is a soluble basic protein belonging to the CC subfamily. Previous studies have been investigated on the correlation between inflammatory factors and clinical events, but there are few studies on the correlation between CCL2 and plaque characteristics. Our study found that the high expression of CCL2 is involved in multiple processes in the genesis and progression of coronary artery disease, and would be a potential clinical prognostic indicator. In addition, high expression of CCL2 may be related to gene pathways such as Nod-like receptor signaling pathway, suggesting that CCL2 is involved in the inflammatory response and immune process of coronary artery disease.

The Relationship of Plasma Decoy Receptor 3 and Coronary Collateral Circulation in Patients with Coronary Artery Disease

Plasma Hyaluronan and Collateral Development in Patients with Coronary Artery Disease

An Elevated Level of BNP in Plasma is Related to the Development of Good Collateral Circulation in Coronary Artery Disease

Relationship Between Serum Thymosin Β4 Levels and Coronary Collateral Development

Reduced Plasma Mir-146A is a Predictor of Poor Coronary Collateral Circulation in Patients with Coronary Artery Disease.

The Association of Plasma Mir-155 and VCAM-1 Levels with Coronary Collateral Circulation.

Increased serum level of soluble vascular endothelial growth factor receptor-1 is associated with poor coronary collateralization in patients with stable coronary artery disease.

Plasma Catestatin: A Useful Biomarker for Coronary Collateral Development with Chronic Myocardial Ischemia.

GW26-e5439 Increased Serum Level of Soluble VEGF Receptor-1 is Associated with Low Coronary Collateralization in Patients with Stable Coronary Artery Disease

Correlation Between Monocyte Chemoattractant Protein-1/Chemokine (C-C Motif) Ligand 2 and Coronary Plaque Characteristics.

Association between platelet-to-lymphocyte ratio and coronary collateral circulation formation

SerpinG1: A Novel Biomarker Associated With Poor Coronary Collateral in Patients With Stable Coronary Disease and Chronic Total Occlusion.

Growth Differentiation Factor 15 and Coronary Collateral Formation

The Correlationship of Plasma Lipoprotein-Associated Phospholipase A2, Hypersensitive C-reactive Protein and D-dimer in Coronary Artery Disease Patients

Plasma Cathepsin L and Its Related Pro/antiangiogenic Factors Play Useful Roles in Predicting Rich Coronary Collaterals in Patients with Coronary Heart Disease.

Decoy Receptor3 in Rheumatoid Arthritis Patient and Its Clinical Relevance

A study in the correlation between vascular factors and plaque imaging morphology of coronary borderline lesions in patients with coronary heart disease

Decoy Receptor 3 (dcr3) As a Biomarker of Tumor Deterioration in Female Reproductive Cancers: A Meta-Analysis.

Non-high-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio serve as a predictor for coronary collateral circulation in chronic total occlusive patients

Relation Between C-X-C Motif Chemokine Receptor 4 Levels and the Presence and Extent of Angiographic Coronary Collaterals in Patients with Chronic Total Coronary Occlusion.

Association of serum C1q/TNF-related protein-3 (CTRP-3) in patients with coronary artery disease